Japan Endotherapy Devices Market - 2024-2031

The Japan Endotherapy Devices market reached US$ 2.70 billion in 2023 and is expected to reach US$ 4.44 billion by 2031, growing at a CAGR of 6.4% during the forecast period 2024-2031.

Endoscopy devices are medical instruments used to visualize and examine internal organs and structures, enabling minimally invasive diagnosis and treatment. They are crucial in fields like gastroenterology, pulmonology, gynecology, and orthopedics, facilitating procedures like colonoscopy, bronchoscopy, and laparoscopy. Advancements in imaging technologies, such as high-definition and 3D visualization, enhance accuracy and precision, reducing the need for invasive surgeries and promoting faster patient recovery.

Market Dynamics: Drivers & Restraints

Technological Advancements in Endoscopy Devices

The endoscopy devices market is growing due to technological advancements like high-definition imaging, 3D visualization, and AI-assisted diagnostics. These technologies improve the precision and efficiency of endoscopic procedures, enabling physicians to detect abnormalities more accurately. AI-powered algorithms enhance real-time image analysis, identifying patterns indicative of conditions like cancer or polyps. Capsule endoscopy offers a more patient-friendly approach to gastrointestinal diagnostics. Flexible robotic endoscopes improve maneuverability and accessibility in complex procedures, minimizing tissue trauma and recovery time.

For instance, in October 2024, Olympus Corporation introduced the Intelligent Endoscopy Ecosystem, a comprehensive medical technology system that integrates hardware, software, services, and data to improve clinical decision-making and operational efficiency.

The "Intelligent Endoscopy Ecosystem" is a vision for the future of endoscopy, focusing on seamless communication and intelligent components. This system uses AI algorithms to improve patient outcomes and operational efficiencies, benefiting hospitals and doctors in the endosuite. Data generated in clinical settings and the application of different software will enhance the system's capabilities.

High Costs and Limited Accessibility

Endoscopy devices and procedures face significant market restraint due to their high costs, which make them unaffordable for many healthcare facilities, especially in low- and middle-income countries. Maintenance and repair expenses also add to the financial burden, limiting their adoption in resource-constrained settings. The lack of skilled professionals to operate these sophisticated devices further complicates the issue, particularly in rural and underserved areas. This disparity results in delayed diagnoses and treatments, negatively impacting patient outcomes. Despite efforts to develop cost-effective solutions and train healthcare professionals, these challenges persist.

For instance, The initial costs for basic endoscope systems, bipolar forceps main body systems, and high-speed drill main body systems are ¥4,500,000, ¥3,500,000, and ¥3,035,000, respectively, excluding video equipment. Despite the high cost-effectiveness and patient-centered clinical outcomes, hospital management struggles to provide FELD appropriately, despite the need for video equipment and compatible video equipment.

Segment Analysis

The Japan endotherapy devices market is segmented based on product type, application and end user.

Product Type:

Endoscopes segment is expected to dominate the endotherapy devices market share

The endoscopes segment holds a major portion of the endotherapy devices market share and is expected to continue to hold a significant portion of the endotherapy devices market share during the forecast period.

Japan's endotherapy devices market is dominated by endoscopes, which are essential for minimally invasive medical procedures. With an aging population and increasing prevalence of gastrointestinal and chronic diseases, Japan has seen a surge in demand for endoscopic interventions. Endoscopes enable precise visualization and access to internal organs for diagnostic and therapeutic purposes, and are widely used in procedures like polypectomy, hemostasis, and stent placements. Japan's robust healthcare infrastructure and focus on preventive care have fueled the adoption of advanced endoscopic technologies, solidifying their crucial role in the nation's endotherapy devices landscape.

Moreover, novel product launches also help the segment to grow during the forecast period, for instance, in October 2024, Olympus has launched two bronchoscopes as part of its EVIS X1 Endoscopy System, which offers the latest in diagnostic and therapeutic bronchoscopy. The bronchoscopes feature slim outer diameters and large working channels, offering access to more distal airways. They are designed with high-definition imaging, allowing for improved suction and flexibility during procedures. The system also allows for the passage of a wide array of diagnostic and therapeutic devices through large working channels, providing physicians with options to successfully address the tracheal bronchial tree.

Gynecology endoscopy segment is the fastest-growing segment in the endotherapy devices market share

The gynecology endoscopy segment is the fastest-growing segment in the endotherapy devices market share and is expected to hold the market share over the forecast period.

Japan's hospitals are key providers of hemodialysis services, offering comprehensive services like patient monitoring, emergency care, and individualized treatment plans. With a universal healthcare system and specialized nephrology departments, hospitals are central to delivering dialysis treatments to the growing patient population.

Gynecology endoscopy is a key component in Japan's endotherapy devices market, focusing on advanced healthcare solutions for women's health. This minimally invasive technique is used for diagnosing and treating gynecological conditions like endometriosis, uterine fibroids, ovarian cysts, and infertility-related issues. With growing awareness of reproductive health and demand for early diagnosis, gynecological endoscopic procedures like hysteroscopy and laparoscopy have gained popularity. These procedures offer reduced pain, shorter recovery times, and minimal scarring, catering to Japan's aging and health-conscious population.

For instance, in September 2024, Olympus Corporation has launched a new 4K camera head, CH-S700-08-LB, for endoscopic urology and gynecology procedures in Europe. The head is compatible with the VISERA ELITE III video system center for surgical endoscopy. The product will be launched in Japan, Hong Kong, and Singapore in September 2024, following regulatory compliance. The technical development was led by Sony Olympus Medical Solutions Corporation, a joint venture between Olympus and Sony Corporation.

Competitive Landscape

The major Japan players in the endotherapy devices market include Olympus Corporation, HOYA Corporation (Pentax Medical), Fujifilm Holdings Corporation, Sumitomo Bakelite Co., Ltd., Shinko Optical Co., Ltd, TOP Corporation, KARL STORZ Japan K.K., Nipro Corporation, Terumo Corporation, Hitachi Ltd. among others.

Emerging Players

The emerging players in the endotherapy devices market include JMS Co., Ltd, Matsunami Glass Ind., Ltd, Asahi Intecc Co., Ltd, Nissha Medical Technologies, Kuraray Co., Ltd, Sysmex Corporation among others.

Key Developments

• In October 2023, Olympus has introduced its next-generation EVIS X1 endoscopy system for gastrointestinal practitioners, along with GIF-1100 and CF-HQ1100DL/I compatible endoscopes. The GIF-1100 is for the upper digestive tract, while the CF-HQ1100DL/I is for the lower digestive tract. The system received approval earlier this year.
• In November 2023, Olympus Corporation has launched its next-generation EVIS X1 endoscopy system in China, marking its availability in all of Olympus' major markets. The advanced system, first released in Europe, Japan, and the U.S. in April 2020, has now received clearance in China, marking its first launch in China since its launch in Europe, Japan, and the U.S. in October 2023.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Japan endotherapy devices market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Component & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.

Academic & Research: Academic Institutions.